Skip to main content

Table 3 Spearman’s rho correlational analysis between urinary uroporphyrin concentration, symptoms, and SF-12 0–100 scores

From: Health-related quality of life in porphyria cutanea tarda: a cross-sectional registry based study

 

Total

Women

Men

Uroporphyrins

Symptoms

Uroporphyrins

Symptoms

Uroporphyrins

Symptoms

Symptoms

.219

 

.023

 

.344

 

PCS

−.202

−.441**

−.133

−.364*

−.284

−.614**

MCS

−.186

−.354**

−.129

−.353*

−.230

−.379

Physical functioning

−.178

−.350**

−.105

−.343

−.206

−.352

Role physical

−.258*

−.406**

−.152

−.414*

−.342

−.422*

Bodily pain

−.179

−.291*

−.147

−.251

−.266

−.392*

General health

−.133

−.372**

−.014

−.258

−.265

−.574**

Vitality

−.007

−.283*

.033

−.356*

−.055

−.230

Social functioning

−.143

−.326*

−.108

−.258

−.072

−.421*

Role emotional

−.230

−.341**

−.131

−.348*

−.306

−.322

Mental health

−.246

−.385**

−.221

−.341

−.304

−.464*

  1. * p < .05; ** p < .01